scispace - formally typeset
N

Naoki Yamamoto

Researcher at Kanazawa Medical University

Publications -  128
Citations -  3473

Naoki Yamamoto is an academic researcher from Kanazawa Medical University. The author has contributed to research in topics: Stem cell & Chemistry. The author has an hindex of 25, co-authored 111 publications receiving 2789 citations. Previous affiliations of Naoki Yamamoto include Fujita Health University & Laboratory of Molecular Biology.

Papers
More filters
Journal ArticleDOI

Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle.

TL;DR: It is suggested that interaction between muscle cells and PDGFRα+ mesenchymal progenitors, not the fate decision of satellite cells, has a considerable impact on muscle homeostasis and is the major contributor to ectopic fat cell formation in skeletal muscle.
Journal ArticleDOI

Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle.

TL;DR: The identification and characterization of a human counterpart to PDGFRα+ mesenchymal progenitors that contribute to adipogenesis and fibrogenesis in mouse skeletal muscle is reported and provides a basis for developing therapeutic strategy to treat muscle diseases.
Journal ArticleDOI

Isolation of multipotent stem cells from mouse adipose tissue

TL;DR: In this article, the p75 neurotrophin receptor (p75NTR) was used as a marker to isolate and collect putative multipotent stem cells from mouse subcutaneous adipose tissue.
Journal ArticleDOI

Wnt/β-Catenin and Kit Signaling Sequentially Regulate Melanocyte Stem Cell Differentiation in UVB-Induced Epidermal Pigmentation

TL;DR: It was demonstrated that Wnt7a triggered McSCs differentiation through β-catenin activation, and Kitl might induce following migration of melanoblasts to epidermis, which will help in developing therapeutic technologies for vitiligo and other pigmentary disorders.
Journal ArticleDOI

Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences

TL;DR: The effect of this unique property of telmisartan on insulin resistance and circulating levels of adiponectin and highly sensitive C-reactive protein in hypertensive patients with type 2 diabetes is studied.